8-K

RCM TECHNOLOGIES, INC. (RCMT)

8-K 2025-05-07 For: 2025-05-07
View Original
Added on April 07, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

________

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported):  May 7, 2025

RCM Technologies, Inc.

(Exact Name of Registrant as Specified in Charter)

Nevada<br><br> <br>(State or Other<br><br> <br>Jurisdiction of<br><br> <br>Incorporation) 1-10245<br><br> <br>(Commission File<br><br> <br>Number) 95-1480559<br><br> <br>(I.R.S. Employer<br><br> <br>Identification No.)
2500 McClellan Avenue, Suite 350
--- ---
Pennsauken, NJ 08109-4613
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: (856) 356-4500

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240-14d-2(b)).
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c)).

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.05 per share RCMT The NASDAQ Stock Market LLC

Item 2.02.       Results of Operations and Financial Condition.

On May 7, 2025, the Registrant issued a press release regarding its financial results for the thirteen weeks ended March 29, 2025.  A copy of the press release is furnished as Exhibit 99 to this report.

The information set forth under this “Item 2.02. Results of Operations and Financial Condition” (including the exhibit) shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference in any filing made by the Registrant pursuant to the Securities Act of 1933, as amended, other than to the extent that such filing incorporates by reference any or all of such information by express reference thereto.

Item 9.01.       Financial Statements and Exhibits.

(a) Financial Statements of Businesses Acquired.

None.

(b) Pro Forma Financial Information.

None.

(c) Shell Company Transactions.

None.

(d) Exhibits.

Exhibit Number
99 Press Release by the Registrant, dated May 7, 2025, furnished in accordance with Item 2.02 of this Current Report on Form 8-K.
104 Cover Page Interactive Data File (formatted as Inline XBRL).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

RCM TECHNOLOGIES, INC.

By: /s/ Kevin D. Miller
Kevin D. Miller
Chief Financial Officer, Treasurer and<br><br> <br>Secretary

Dated: May 7, 2025

ex_810282.htm

Exhibit 99

image01.jpg

RCM Technologies, Inc. Tel: 856.356.4500 Corporate Contacts:
2500 McClellan Avenue info@rcmt.com Bradley S. Vizi
Pennsauken, NJ 08109 www.rcmt.com Executive Chairman
Kevin D. Miller
Chief Financial Officer

P R E S S   R E L E A S E

RCM TECHNOLOGIES, INC. ANNOUNCES

FIRST QUARTER RESULTS

Pennsauken, NJ – May 7, 2025 -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of solutions designed to enhance the operational performance of its customers through the deployment of advanced engineering, specialty health care, and information technology services, today announced financial results for the thirteen weeks ended March 29, 2025.

RCM Technologies reported revenue of $84.5 million for the thirteen weeks ended March 29, 2025 (the current quarter), an increase of 17.4% compared to $71.9 million for the thirteen weeks ended March 30, 2024 (the comparable prior quarter). Gross profit was $22.0 million for the current quarter, a 7.9% increase compared to $20.4 million for the comparable prior quarter.  The Company experienced GAAP net income of $4.2 million, or $0.54 per diluted share, for the current quarter compared to $4.0 million, or $0.48 per diluted share, for the comparable prior quarter. The Company experienced adjusted EBITDA (non-GAAP) of $7.8 million for the current quarter, as compared to $6.8 million for the comparable prior quarter.  The Company experienced $0.63 of adjusted net income per diluted share (non-GAAP) for the current quarter as compared to $0.53 for the comparable prior quarter.

Bradley Vizi, Executive Chairman of RCM Technologies, commented, “The internals of our business continue to strengthen at an increasing rate. We believe the company is well positioned based on the thoughtful investment strategy we have deployed, and significant reductions in our share count should enhance the compounding of returns to the benefit of shareholders.”

Kevin Miller, Chief Financial Officer of RCM Technologies, commented, “We are very pleased with our cash flow this quarter, as we generated $16.7 million in cash flow from operations and reduced our net debt by $12.0 million while retiring shares and growing earnings at a healthy clip.”


Conference Call

On Thursday, May 8, 2025, RCM Technologies will host a conference call to discuss these results. The call will begin at 10:30 a.m. Eastern Time. The dial-in number is (888) 272-8703.

About RCM

RCM Technologies (NasdaqGM: RCMT) is a business and technology solutions provider with world-class talent in key market segments. We help design, build, and enable the Industries of Tomorrow, Today. Operating at the intersection of resources, critical infrastructure and modernization of industries, RCM is a provider of services in Health Care, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions. www.rcmt.com.

The statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995. They are subject to various risks, uncertainties, and other factors that could cause the Company’s actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “project,” “intend,” “believe,” “plan,” “seek,” “could,” “can,” “should,” “are confident” or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, and our perceptions of historical trends, current conditions, expected future developments, and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to demand for the Company’s services, expectations regarding our future revenues and other financial results, such as cash flows, our pipeline, and potential project wins, and our expectations for investment and growth in our business. Such statements are based on current expectations that involve several known and unknown risks, uncertainties, and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties, and other factors may emerge from time to time that could cause the Company’s actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties, and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law.

Tables to Follow


RCM Technologies, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(In Thousands, Except Share and Per Share Amounts)

Thirteen Weeks Ended
March 29,<br><br> <br>2025 March 30,<br><br> <br>2024
Revenue $84,473 $71,939
Cost of services 62,495 51,572
Gross profit 21,978 20,367
Selling, general and administrative 14,971 14,199
Depreciation and amortization of property and equipment 424 287
Amortization of acquired intangible assets - 45
Operating income 6,583 5,836
Other expense, net 698 426
Income before income taxes 5,885 5,410
Income tax expense 1,699 1,458
Net income $4,186 $3,952
Diluted net earnings per share data $0.54 $0.48
Diluted weighted average shares outstanding 7,741,481 8,170,839

RCM Technologies, Inc.

Supplemental Operating Results on a Non-GAAP Basis

(Unaudited)

(In Thousands, Except Per Share Amounts)

The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures.  Our management believes that these non-GAAP financial measures (“Adjusted operating income,” “EBITDA,” “Adjusted EBITDA,” “Adjusted net income” and “Adjusted diluted net earnings per share”) are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors’ overall understanding of our current financial performance and period-to-period comparisons.  Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share should not be considered alternatives to operating income or net income, as the case may be, as an indicator of performance.  In addition, Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows.  We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read-only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

The following unaudited table presents the Company’s GAAP operating income and GAAP net income and the corresponding adjustments used to calculate Adjusted operating income, EBITDA, Adjusted EBITDA, Adjusted net income and Adjusted diluted net earnings per share for the thirteen weeks ended March 29, 2025 and March 30, 2024.

Thirteen Weeks Ended
March 29,<br><br> <br>2025 March 30,<br> 2024
(Unaudited)
GAAP operating income $6,583 5,836
Adjustments
Equity compensation 773 635
Adjusted operating income (non-GAAP) $7,356 6,471
GAAP net income $4,186 3,952
Income tax expense 1,699 1,458
Interest expense, net 651 478
Depreciation of property and equipment 424 287
Amortization of acquired intangible assets - 45
EBITDA (non-GAAP) $6,960 6,220
Adjustments
Loss (gain) on foreign currency transactions 47 (52
Equity compensation 773 635
Adjusted EBITDA (non-GAAP) $7,780 6,803

All values are in US Dollars.


RCM Technologies, Inc.

Supplemental Operating Results on a Non-GAAP Basis (Continued)

(Unaudited)

(In Thousands)

Thirteen Weeks Ended
March 29,<br> 2025 March 30,<br> 2024
(Unaudited)
GAAP net income 4,186 3,952
Adjustments
Loss (gain) on foreign currency transactions 47 (52
Equity compensation 773 635
Tax impact from normalized rate (111 (160
Adjusted net income (non-GAAP) 4,895 4,375
GAAP diluted net earnings per share 0.54 0.48
Adjustments
Loss (gain) on foreign currency transactions 0.01 (0.01
Equity compensation 0.10 0.08
Tax impact from normalized rate (0.02 (0.02
Adjusted diluted net earnings per share (non-GAAP) 0.63 0.53

All values are in US Dollars.


RCM Technologies, Inc.

Summary of Selected Income Statement Data

(Unaudited)

(In Thousands)

Thirteen Weeks Ended March 29, 2025
Specialty<br> Health Care Engineering Life Sciences,<br> Data and<br> Solutions Consolidated
Revenue 43,283 32,142 9,048 84,473
Cost of services 31,080 25,957 5,458 62,495
Gross profit 12,203 6,185 3,590 21,978
Gross profit margin 28.2 19.2 39.7 26.0

All values are in US Dollars.

Thirteen Weeks Ended March 30, 2024
Specialty<br> Health Care Engineering Life Sciences,<br> Data and<br> Solutions Consolidated
Revenue 38,182 23,505 10,252 71,939
Cost of services 27,108 18,003 6,461 51,572
Gross profit 11,074 5,502 3,791 20,367
Gross profit margin 29.0 23.4 37.0 28.3

All values are in US Dollars.


RCM Technologies, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(In Thousands, Except Share Amounts)

March 29, December 28,
2025 2024
(Unaudited)
Current assets:
Cash and cash equivalents $5,181 $4,729
Accounts receivable, net of provision for credit losses of 1,570<br>  at March 29, 2025 and December 28, 2024 68,390 77,960
Transit accounts receivable 7,165 7,315
Prepaid expenses and other current assets 5,240 7,034
85,976 97,038
Property and equipment, net 7,371 7,368
Other assets:
Deposits 233 230
Deferred tax assets, foreign 125 120
Goodwill 22,147 22,147
Operating right of use asset 5,140 5,174
27,645 27,671
$120,992 $132,077

All values are in US Dollars.

Current liabilities:
Accounts payable and accrued expenses 14,509 13,369
Transit accounts payable 19,327 23,870
Accrued payroll and related costs 12,581 9,929
Finance lease payable 706 698
Income taxes payable 273 346
Operating right of use liability 1,107 1,046
Contingent consideration from acquisitions 212 212
Deferred revenue 4,519 4,163
53,234 53,633
Deferred income taxes, net, domestic 4,526 4,526
Finance lease payable, net of current position 932 1,112
Operating right of use liability, net of current position 4,286 4,355
Borrowings under line of credit 23,414 34,967
86,392 98,593
Contingencies (note 15)
Stockholders’ equity:
Preferred stock, 1.00 par value; 5,000,000 shares authorized;
- -
Common stock, 0.05 par value; 40,000,000 shares authorized;
895 890
Additional paid-in capital 118,956 118,845
Accumulated other comprehensive loss (2,918 (2,920
Accumulated deficit (1,752 (5,938
Treasury stock, 10,419,691 shares at March 29, 2025 and
(80,581 (77,393
34,600 33,484
120,992 132,077

All values are in US Dollars.


RCM Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(In Thousands)

Thirteen Weeks Ended
March 29,<br> 2025 March 30,<br> 2024
Net income 4,186 3,952
Adjustments to reconcile net income to cash<br><br> <br>used in operating activities 1,459 1,250
Changes in operating assets and liabilities:
Accounts receivable 9,558 (2,802
Prepaid expenses and other current assets 1,787 120
Net of transit accounts receivable and payable (4,393 (219
Accounts payable and accrued expenses 1,358 1,345
Accrued payroll and related costs 2,665 976
Right of use liabilities (241 (304
Income taxes payable (71 451
Deferred revenue 356 1,633
Deposits (4 24
Total adjustments 12,474 2,474
Net cash provided by operating activities 16,660 6,426
Net cash used in investing activities (427) (669
Net cash used in financing activities (15,583 (9,714
Effect of exchange rate changes on cash and cash equivalents (198 (228
Increase (decrease) in cash and cash equivalents 452 (4,185
Common stock repurchase (3,188 -
Retirement of common shares (939) (1,317

All values are in US Dollars.